Ryuko Nakayama

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara et al. · Proceedings of the National Academy of Sciences · 2011 · 99 citations · Full text

Cyclosporine A for Chemotherapy-Resistant Subcutaneous Panniculitis-Like T Cell Lymphoma with Hemophagocytic Syndrome

Shinsuke Mizutani, Junya Kuroda, Yuji Shimura et al. · Acta Haematologica · 2011 · 40 citations

Immunodeficiencies, Immunology, Pathology +17

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis

Hisao Nagoshi, Junya Kuroda, Tsutomu Kobayashi et al. · International Journal of Hematology · 2013 · 33 citations

Lymphoid Neoplasia, Hematology, Histopathology +8

FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors

Miki Kiyota, Junya Kuroda, Mio Yamamoto‐Sugitani et al. · APOPTOSIS · 2013 · 32 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +10

RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma

Yuji Shimura, Junya Kuroda, Masaki Ri et al. · Molecular Cancer Therapeutics · 2012 · 29 citations

Potential Therapeutic Target, Tumor Biology, Hematological Malignancy +15